Moreover, berberine diminished inflammation and lowered the levels of TNF-α, IL-6, and IL-1β in rats with non-alcoholic fatty liver disease by regulating the TLR4/MyD88/NF-κB signaling pathway [74]. Here, IL1B is linked to alcoholic fatty liver disease.